Literature DB >> 21852452

JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.

Raphael P Viscidi1, Nina Khanna, Chen S Tan, Xiuhung Li, Lisa Jacobson, David B Clifford, Avindra Nath, Joseph B Margolick, Keerti V Shah, Hans H Hirsch, Igor J Koralnik.   

Abstract

We examined whether prediagnostic John Cunningham virus (JCV) antibodies and viremia are predictors of progressive multifocal leukoencephalopathy (PML) in 83 PML cases and 240 human immunodeficiency virus (HIV) disease-matched controls. JCV viremia was not predictive of PML, but some patients showed higher anti-JCV immunoglobulin G (IgG) responses 6 months prior to diagnosis.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21852452      PMCID： PMC3166351          DOI： 10.1093/cid/cir507

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; D Boden; V X Mai; C I Lord; N L Letvin
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

2.  Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy.

Authors:  P Ferrante; R Caldarelli-Stefano; E Omodeo-Zorini; A E Cagni; L Cocchi; F Suter; R Maserati
Journal:  J Med Virol       Date:  1997-07       Impact factor: 2.327

Review 3.  Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions.

Authors:  Joseph R Berger
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

4.  HIV-1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus.

Authors:  Hans H. Hirsch; Pascal R. A. Meylan; Werner Zimmerli; Anne Iten; Manuel Battegay; Peter Erb
Journal:  Clin Microbiol Infect       Date:  1998       Impact factor: 8.067

5.  JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

Authors:  Nina Khanna; Marcel Wolbers; Nicolas J Mueller; Christian Garzoni; Renaud A Du Pasquier; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Raphael Viscidi; Manuel Battegay; Hans H Hirsch
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

Authors:  Wendy A Knowles; Pam Pipkin; Nick Andrews; Andrew Vyse; Philip Minor; David W G Brown; Elizabeth Miller
Journal:  J Med Virol       Date:  2003-09       Impact factor: 2.327

7.  Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.

Authors:  Dana E Rollison; Kathy J Helzlsouer; Ji-Hyun Lee; William Fulp; Sandra Clipp; Judy A Hoffman-Bolton; Anna R Giuliano; Elizabeth A Platz; Raphael P Viscidi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

Review 8.  Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.

Authors:  Kenneth R Carson; Daniele Focosi; Eugene O Major; Mario Petrini; Elizabeth A Richey; Dennis P West; Charles L Bennett
Journal:  Lancet Oncol       Date:  2009-08       Impact factor: 41.316

9.  Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.

Authors:  Mary K Grabowski; Raphael P Viscidi; Joseph B Margolick; Lisa P Jacobson; Keerti V Shah
Journal:  J Med Virol       Date:  2009-07       Impact factor: 2.327

10.  Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.

Authors:  Nina Khanna; Luigia Elzi; Nicolas J Mueller; Christian Garzoni; Matthias Cavassini; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Manuel Battegay; Hans H Hirsch
Journal:  Clin Infect Dis       Date:  2009-05-15       Impact factor: 9.079
View more
  21 in total

Review 1.  Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors:  Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal:  Rev Med Virol       Date:  2015-12-14       Impact factor: 6.989

2.  Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.

Authors:  Chen Sabrina Tan; Thomas A Broge; Long Ngo; Sarah Gheuens; Raphael Viscidi; Evelyn Bord; Jacalyn Rosenblatt; Michael Wong; David Avigan; Igor J Koralnik
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-27       Impact factor: 5.742

3.  Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays.

Authors:  Piotr Kardas; Mohammadreza Sadeghi; Fabian H Weissbach; Tingting Chen; Lea Hedman; Eeva Auvinen; Klaus Hedman; Hans H Hirsch
Journal:  Clin Vaccine Immunol       Date:  2014-09-24

4.  Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Authors:  Jérôme Hadjadj; Aurélien Guffroy; Christophe Delavaud; Guillaume Taieb; Isabelle Meyts; Anne Fresard; Nathalie Streichenberger; Anne-Sophie L'Honneur; Flore Rozenberg; Maud D'Aveni; Claire Aguilar; Jérémie Rosain; Capucine Picard; Nizar Mahlaoui; Marc Lecuit; Olivier Hermine; Olivier Lortholary; Felipe Suarez
Journal:  J Clin Immunol       Date:  2018-12-14       Impact factor: 8.317

5.  JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.

Authors:  Elena Uleri; Gabriele Ibba; Claudia Piu; Maurizio Caocci; Stefania Leoni; Giannina Arru; Caterina Serra; GianPietro Sechi; Antonina Dolei
Journal:  J Neurovirol       Date:  2016-11-03       Impact factor: 2.643

6.  BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients.

Authors:  Francesca Rossi; Xiuhong Li; Lisa Jacobson; Andrew J Levine; Yue Chen; Frank J Palella; Joseph Margolick; Raphael Viscidi
Journal:  Virology       Date:  2015-09-07       Impact factor: 3.616

7.  JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.

Authors:  T Wittmann; N Horowitz; N Benyamini; I Henig; T Zuckerman; J M Rowe; Z Kra-Oz; M Szwarcwort Cohen; I Oren; I Avivi
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

8.  JC virus antibody status underestimates infection rates.

Authors:  Joseph R Berger; Sidney A Houff; Julie Gurwell; Nubia Vega; Craig S Miller; Robert J Danaher
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

9.  Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants.

Authors:  Caroline F Ryschkewitsch; Peter N Jensen; Eugene O Major
Journal:  J Clin Virol       Date:  2013-04-23       Impact factor: 3.168

Review 10.  Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.

Authors:  Thorsten Bartsch; Torge Rempe; Arne Wrede; Frank Leypoldt; Wolfgang Brück; Ortwin Adams; Axel Rohr; Olav Jansen; Christian Wüthrich; Günther Deuschl; Igor J Koralnik
Journal:  Ann Neurol       Date:  2015-07-31       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.